HER-2 pulsed Dendritic Cell Vaccine

BIOLOGICAL3 trials

Sponsors

Abramson Cancer Center at Penn Medicine, H. Lee Moffitt Cancer Center and Research Institute

Conditions

Breast CancerDCIS

Phase 1

HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy

CompletedNCT02061423

H. Lee Moffitt Cancer Center and Research InstituteBreast Cancer

Start: 2014-04-08End: 2024-02-21Updated: 2024-08-02

DC Vaccine for Patients With Ductal Carcinoma In Situ

CompletedNCT02061332

Abramson Cancer Center at Penn MedicineBreast Cancer, DCIS

Start: 2009-07-31End: 2015-10-07Updated: 2020-04-10

HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer

CompletedNCT02063724

H. Lee Moffitt Cancer Center and Research InstituteBreast Cancer

Start: 2014-10-01End: 2022-09-01Updated: 2026-02-20